Control of viral diseases by immunization/vaccine Flashcards

1
Q

What is a veccine ?

A

a preparation of suspensions of killed or attenuated microorganisms, or products or derivatives of microorganisms, that can be used safely to induce an immune response and confers prevention of infection, a reduction in disease severity or a decreased rate of hospitalization on subsequent exposure to a pathogen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is an antigenic ?

A

substances that cause the body’s immune system to react, especially causing it to produce antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are vaccines made of that make them procure immunity ?

A

they contain virus proteins with antigenic areas called epitopes
(viral epitopes induce both B-cell and T-cell immunity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

adjuvant:

A

substance that enhances the body’s immune system to an antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Immunoprophylaxis against viral illnesses

A

vaccines or antibodies-containing preparatons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Active Prophylaxis (Vaccines)

A

the normal vaccines to immunise people

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Passive Prophylaxis (immunity)

A

antibodies from another host (majorly made of blood and contain antibodies), used when the person is diseased and cannot be protected by vaccination)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what generates the memory of antibodies ?

A

it’s the memory B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what happens if the incubation period is too short (of the pathogen)

A

the memory response may not be enough because memory cell B doesn’t have the time to make the antibodies reach the protection treshold and the pathogen has a rapid onset of symptoms (that means cell B don’t have time to re-produce antibodies after the 1st time)
but in some cases after the primary vaccination the antibodies remain above the protection treshold and provide lifelong immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Passive immunisation:

A

(immunoglobulin), it only stays for 4 months and then the antibodies decay), it’s just a partial protection
in some cases, it has an outward reaction and instead the antibodies help the virus spread (dengue)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

prophylactic immunisation VS passive:

A

the prophylactic one is fully effective prior to exposure and can still be effective postexposure (at early point); on the other hand, the passive one when administered postexposure decreases its effectiveness once the disease progresses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

viral vaccines function:

A

prevent infection by antigenic stimulation of the host and induction of memory T cells, resulting in the generation of neutralizing antibody and cytotoxic T cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Inactivated (killed) vaccines

A

consist of chemically inactivated whole virions (e.g. rabies, formalin-killed polio vaccine).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Non-living vaccines

A

prepared from fractionated virus containing immunogenic proteins, (e.g. ‘split’ influenza vaccine), or by recombinant DNA techniques (e.g. hepatitis B vaccine) or nucleic acid (SARS-CoV-2).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Live vaccines

A

prepared from viruses,which,by manipulation in the laboratory are no longer pathogenic but retain their immunogenicity (e.g. YF, oral polio, mumps, measles, rubella).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

some reminders about vaccines

A
  • immunization is one of the most cost-effective public health measures available.
  • Certain viruses remain uncontrolled by immunization because of multiplicity of serotypes, i.e. rhinoviruses and arboviruses, or major antigenic change, i.e. HIV.
  • New approaches to vaccine development include recombinant DNA techniques, the use of nucleic acids as the immunogen and the improvement of adjuvants and new adjuvants targeting the innate immune system open new perspective in vaccination progress
17
Q

Bacteria VS virus

A
  • Bacteria: many antibiotics + highly selective
  • virus: use host cell metabolism + toxicity + selectively difficult
18
Q

Why Has Development of Antiviral Drugs Lagged Behind the introduction of Antibiotics?

A
  • virus use cell host so it’s hard to find inhibitors
  • with acute viral diseases by the time the patient seeks treatment the virus is already at its peak replication
  • problems w intracellular drug concentration or distribution to site of infection
  • screening + testing = difficult cos it was hard to have lab rats
  • it took a long time to put a diagnosis on viral infections
  • drugs in vitro were smh inaffective in vivo
19
Q

drugs for diff viruses:

A
  • herpes: acyclovir
    ganciclovir
    foscarnet
  • HIV: - fusion inhibitor - protease inhibitor - reverse transcriptase inhibitors: nucleosides + nonnucleosides
  • influenza: amantadine, zanamivir
  • HBV/HCV: INF alpha + lamivudine + ribavirin